World of DTC Marketing
JUNE 22, 2022
Advanced economies typically spend about 10% of GDP on keeping their citizens in good health, a share that is rising as populations age. America’s profit-riddled healthcare-industrial complex consumes 17% of GDP, equivalent to $3.6trn a year. That is unsustainable. However, changes are slowly being implemented that could lower healthcare costs.
Dominic Tyer
JUNE 18, 2022
Chief digital and technology officer Lidia Fonseca gives a fascinating insight into how the pharmaceutical companies has been transforming itself.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JUNE 24, 2022
The Greek state has filed a lawsuit against Novartis , asking for € 214 million in compensation for non-pecuniary damages* the country may have suffered due to alleged illegal payments to government officials and healthcare providers. Commenting on the lawsuit , Greece’s Health Minister Thanos Plevris, stated that the country is seeking compensation for the damage it has suffered “from the actions that Novartis itself has admitted to in the USA that concerns payments to doctors.”.
Clarivate
JUNE 21, 2022
Each year, the Journal Citation Reports (JCR) release provides a summary of the network of scholarly citations from the prior year of Web of Science coverage. It is a snapshot of the continually evolving research landscape. “It’s tough to make predictions, especially about the future.”. Baseball player Yogi Berra. As we approach this year’s JCR release at the end of this month, we reviewed factors that may affect the published metrics.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
World of DTC Marketing
JUNE 20, 2022
Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. In addition, the patient journey is different for each product category and audience. Some will lead to more online research, while others may not. The hottest pharma product is Lilly’s diabetes drug, hyped by the media as helping patients lose weight.
pharmaphorum
JUNE 23, 2022
Eisai’s digital tool to allow self-assessment of cognitive performance – NouKNOW – will be used in a Japanese project aimed at improving the management of dementia. The smartphone app – which uses a cognition-checking algorithm developed by Australian digital health company Cogstate – will be deployed in Bunkyo City, Tokyo in a dementia monitoring programme.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JUNE 23, 2022
Mental health is bucking the overall trend in telehealth utilization. A new report found that telehealth accounted for 87% of mental health appointments booked last month. That percentage is continuing to climb, despite virtual care visits declining across all other specialties.
PharmaTimes
JUNE 21, 2022
Pre-clinical screening technology could increase cancer test numbers by 50 times
PharmExec
JUNE 20, 2022
The world’s largest cancer research meeting, the American Society of Clinical Oncology (ASCO) Annual Meeting, recently convened in person in Chicago after two years of being held virtually. Sara Baker and Kristine Austria Fan of Marina Maher Communications provide their takeaways from the meeting.
Pharmaceutical Technology
JUNE 24, 2022
As regulatory agencies gear up for another round of Covid-19 vaccine deliberations centered on emerging variants, Moderna has released data on its booster’s efficacy against Omicron subvariants. In addition to providing protection against the Omicron BA.1 variant, on 22 June, Moderna said its booster also showed a “potent” antibody response against Omicron subvariants BA.4 and BA.5.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
JUNE 23, 2022
Leaders in healthcare draw attention to the myriad ways cloud computing technology is transforming healthcare.
PharmaTimes
JUNE 20, 2022
The discovery may lead to development of drugs that halt disease progression and stop memory loss
European Pharmaceutical Review
JUNE 24, 2022
2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. It is an exciting year… but whether the changes will be a net positive or a net negative is yet to be seen” Maarten Meulenbelt, Partner, Sidley Austin LLP. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review.
pharmaphorum
JUNE 22, 2022
Pfizer has harnessed the expertise of health data specialist Truveta to provide close monitoring of safety and other signals for its products, including COVID-19 vaccine Comirnaty, almost in real-time. Truveta’s platform is based on electronic medical record data – updated daily – for more than 50 million people in the US, harvesting anonymised patient care information from tens of thousands of clinical care sites across 42 states.
MedCity News
JUNE 24, 2022
An Intellia Therapeutics therapy that uses CRISPR to perform in vivo genomic edits has clinical data showing that the therapeutic effects continue for a year in patients. The biotech now plans to speak with regulators about the design for a pivotal clinical trial testing this therapy, a potential one-time treatment for a rare inherited disease.
Pharmaceutical Technology
JUNE 23, 2022
The European Commission (EC) has approved Novartis’ Tabrecta (capmatinib) as a monotherapy to treat advanced non-small cell lung cancer (NSCLC) in adults. The treatment is intended for patients with NSCLC harbouring alterations leading to mesenchymal-epithelial-transition factor gene (MET) exon 14 (METex14) skipping and for those who need systemic therapy after previous treatment with immunotherapy and/or platinum-based chemotherapy.
PharmaTimes
JUNE 22, 2022
Novartis receives approval from the European Commission for Tabrecta for the treatment of non-small cell lung cancer
pharmaphorum
JUNE 24, 2022
Last year, AstraZeneca reported that a new drug to treat Wilson disease developed by its Alexion rare diseases unit had hit the mark in a phase 3 trial, setting it on course for regulatory filings. Now, the data has been revealed – and according to investigators could transform treatment. Wilson disease is a rare and progressive genetic condition in which the body’s process for removing excess copper is broken, allowing it to build to toxic levels and damage the liver, brain and other vita
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
JUNE 24, 2022
The Future of Virtual-First Care eBook, sponsored by Wheel, explores some of the challenges and trends in virtual-first care. It also offers clues as to how healthcare stakeholders envision the future of virtual health.
Pharmaceutical Technology
JUNE 24, 2022
Novavax has obtained emergency use authorization (EUA) for its Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), from the Taiwan Food and Drug Administration for use in people of the age 18 years and above. The protein-based vaccine is engineered from the genetic sequence of the SARS-CoV-2 virus’ initial strain. Developed utilising Novavax’s recombinant nanoparticle technology to generate antigen obtained from the coronavirus spike (S) protein, the vaccine is also formulated with the company’s saponin-
PharmaTimes
JUNE 23, 2022
Global surveillance systems show that recorded cases do not include any deaths
Medgadget
JUNE 21, 2022
Clinical researchers at Nagoya City University in Japan have tested an AI-powered surgical robot in its ability to assist with percutaneous nephrolithotomy, which is a minimally invasive procedure to remove large kidney stones. The technique involves accessing the kidney through the skin, and typically requires a highly experienced surgeon. The robot, called the Automated Needle Targeting with X-ray (ANT-X) was developed by NDR Medical Technology , a medical startup based in Singapore.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
JUNE 23, 2022
Medallion — a provider management platform that automates licensing, continuing education tracking, credentialing and compliance — has completed three funding rounds in one year. On Thursday, it closed a $35 million Series C round, which will be used to help the startup attract more hospital and health system customers.
Copyright Clearance Center
JUNE 24, 2022
The post ALA Annual Conference Returns to Washington appeared first on Copyright Clearance Center.
eMediWrite
JUNE 21, 2022
Every year, pharma marketing teams engage in multi-phased, cross-functional, multi-organizational strategic planning and also in aligning work-stream dubbed “Brand Planning” by many in the industry. Brand planning is often a three-phased process that includes Strategic Planning, Tactical Planning, and Budget Planning. Every quarter, marketing teams (Consumer, HCP, and Payer) align on the brand’s mission, strategic imperatives, and high-level programs.
Salesforce
JUNE 21, 2022
Healthcare and life sciences organizations are no strangers to change. But as the pandemic took hold, it forced change in a way the industry hadn’t seen before. Much of the workforce went remote seemingly overnight, and companies had to adapt — and innovate — fast. In fact, according to a survey of healthcare and life sciences leaders , 50% said remote and hybrid work settings were a top internal disruption factor at the start of the pandemic.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
MedCity News
JUNE 23, 2022
Confidentiality agreements typically prevent the public from obtaining a window into the cases against pharmacy behemoths but a public court filing makes this one different.
Copyright Clearance Center
JUNE 19, 2022
The post Cryptocurrency and Cryptic Copyright appeared first on Copyright Clearance Center.
pharmaphorum
JUNE 23, 2022
Novartis has shouldered its way into the in vivo gene editing category via a deal with US biotech Precision BioSciences, focused on a therapy for sickle cell disease (SCD). The Swiss pharma group is paying $75 million upfronting cash and equity to get the ball rolling on the collaboration, with another $1.4 billion in potential milestones if the project advances through development and onto the market.
Medgadget
JUNE 22, 2022
Engineers at the University of California Los Angeles have developed “meta-bots,” which are fingernail sized robots that can move, sense, and navigate their environment. Strikingly, the robots are essentially ready for use when they emerge from the 3D printer, and consist of piezoelectric actuators that can respond to or generate electricity. The robots consist of an intricate structure of piezoelectric components that allow them to rapidly flex and rotate.
Expert insights. Personalized for you.
227 
Let's personalize your content